Biblio
“Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 78, no. 1, pp. 245-263, 2020.
, “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
, “Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 877-883, 2020.
, “Potential for Digital Monitoring to Enhance Wellbeing at Home for People with Mild Dementia and Their Family Carers.”, J Alzheimers Dis, vol. 73, no. 3, pp. 867-872, 2020.
, “Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.”, J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
, “Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 391-405, 2020.
, “Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.”, J Alzheimers Dis, vol. 77, no. 2, pp. 547-550, 2020.
, “The Prevalence of Dementia: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1157-1166, 2020.
, “Quantitative Mass Spectrometric Assay of Whole and CNBr-Cleaved Amyloid-β Peptides in Human Brain.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1637-1645, 2020.
, “Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1385-1405, 2020.
, “The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 3, pp. 1119-1127, 2020.
, “Resilience of Alzheimer's Disease to COVID-19.”, J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
, “A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 849-865, 2020.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 795-806, 2020.
, “Role of Executive Functions in the Conversion from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 77, no. 2, pp. 641-653, 2020.
, “Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic Mice.”, J Alzheimers Dis, 2020.
, “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
, “Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.”, J Alzheimers Dis, vol. 79, no. 2, pp. 807-817, 2020.
, “Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 683-697, 2020.
, “Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.”, J Alzheimers Dis, vol. 74, no. 2, pp. 501-508, 2020.
, “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
, “Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).”, J Alzheimers Dis, vol. 73, no. 1, pp. 125-133, 2020.
, “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
,